Ignite Creation Date:
2024-05-06 @ 1:46 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04123470
Status:
COMPLETED
Last Update Posted:
2023-08-29
First Post:
2019-10-09
Brief Title:
A Phase III Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma
Sponsor:
Lokon Pharma AB
Organization:
Lokon Pharma AB
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-09
First Submit QC Date:
October 9 2019
Study First Post Date:
2019-10-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-12
Last Update Post Date:
2023-08-29
Last Update Post Date Type:
ACTUAL